.

.


LogOff Samples
The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease.
    Microbiology and immunology (Microbiol Immunol ) Vol: 47 Issue 6 Pages: 371-8
    Pub: 2003 Epub:
    • Shiba T
    • Aiba Y
    • Ishikawa H
    • Ushiyama A
    • Takagi A
    • Mine T
    • Koga Y

  2. Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis.
    PloS one (PLoS One ) Vol: 12 Issue 4 Pages: e0175935
    Pub: 2017 Epub: 2017 Apr 24
    • Celiberto LS
    • Bedani R
    • Dejani NN
    • Ivo de Medeiros A
    • Sampaio Zuanon JA
    • Spolidorio LC
    • Tallarico Adorno MA
    • Amâncio Varesche MB
    • Carrilho Galvão F
    • Valentini SR
    • Font de Valdez G
    • Rossi EA
    • Cavallini DCU

  3. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
    Journal of applied microbiology (J Appl Microbiol ) Vol: 100 Issue 6 Pages: 1324-32
    Pub: 2006 Jun Epub:
    • Hütt P
    • Shchepetova J
    • Lõivukene K
    • Kullisaar T
    • Mikelsaar M

  4. Curated database of commensal, symbiotic and pathogenic microbiota
    Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages:
    Pub: 2014 Jun Epub:
    • D'Adamo Peter

  5. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota
    Scientific Reports (Sci Rep ) Vol: 7 Issue Pages: 8770
    Pub: 2017 Aug 18 Epub: 2017 Aug 18
    • Fang D
    • Shi D
    • Lv L
    • Gu S
    • Wu W
    • Chen Y
    • Guo J
    • Li A
    • Hu X
    • Guo F
    • Ye J
    • Li Y
    • Li L

  6. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial.
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (Korean J Gastroenterol ) Vol: 65 Issue 4 Pages: 215-21
    Pub: 2015 Apr Epub:
    • Shadnoush M
    • Hosseini RS
    • Khalilnezhad A
    • Navai L
    • Goudarzi H
    • Vaezjalali M

  7. Bifidobacterium adolescentis IM38 ameliorates high-fat diet-induced colitis in mice by inhibiting NF-?B activation and lipopolysaccharide production by gut microbiota.
    Nutrition research (New York, N.Y.) (Nutr Res ) Vol: 41 Issue Pages: 86-96
    Pub: 2017 May Epub: 2017 Apr 19
    • Lim SM
    • Kim DH

  8. Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria.
    Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45
    Pub: 2008 Aug Epub: 2008 Jun 6
    • Salazar N
    • Gueimonde M
    • Hernández-Barranco AM
    • Ruas-Madiedo P
    • de los Reyes-Gavilán CG

  9. Bifidobacteria exert species-specific effects on constipation in BALB/c mice.
    Food & function (Food Funct ) Vol: 8 Issue 10 Pages: 3587-3600
    Pub: 2017 Oct 18 Epub:
    • Wang L
    • Hu L
    • Xu Q
    • Jiang T
    • Fang S
    • Wang G
    • Zhao J
    • Zhang H
    • Chen W

  10. Benefits of Bifidobacterium animalis subsp. lactis Probiotic in Experimental Periodontitis.
    Journal of periodontology (J Periodontol ) Vol: 88 Issue 2 Pages: 197-208
    Pub: 2017 Feb Epub: 2016 Sep 23
    • Oliveira LF
    • Salvador SL
    • Silva PH
    • Furlaneto FA
    • Figueiredo L
    • Casarin R
    • Ervolino E
    • Palioto DB
    • Souza SL
    • Taba M Jr
    • Novaes AB Jr
    • Messora MR

Full list available by paid subscriptions

For More information see this summary.